Diagnosis and Treatment of Female Sexual Dysfunction

Hana Yoon

doi:10.5124/jkma.2003.46.1.51

Journal List > J Korean Med Assoc > v.46(1) > 1080255

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Yoon: Diagnosis and Treatment of Female Sexual Dysfunction

Continuing Education Column

Journal of the Korean Medical Association

Journal of the Korean Medical Association 2003; 46(1): 51-55.

Published online: 31 January 2003

DOI: https://doi.org/10.5124/jkma.2003.46.1.51

Diagnosis and Treatment of Female Sexual Dysfunction

Hana Yoon, M.D.

Department of Urology, Ewha Womans' University College of Medicine, Mokdong Hospital, Korea. wowhana@ewha.ac.kr

(open-access):

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Woman's sexual response is composite and complex. However, recent understanding of the causes of sexual dysfunction in women highlights not only psychological but also organic aspects. Taking patients' medical and sexual history and careful physical examinations are very important to make diagnosis and uncover conditions that cause problems in their sexual activities. Multimodal treatment with good support from the sexual partner is usually essential.

Keywords: Female sexual dysfunction, Diagnosis, Treatment

References

1. Park K, Goldstein I, Andry C, Siroky MB, Krane RJ, Azadzoi KM. Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement and clitoral erectile insufficiency. Int J Impot Res. 1997. 9:27–37.

2. Goldstein I, Berman J. Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes. Int J Impot res. 1998. 10:S84–S90.

3. Min KS, O'Conell L, Munarriz R, Huang YH, Choi S, Kim N, et al. Experimental models for the investigation of female sexual function and dysfunction. Int J Impot Res. 2001. 13:151–156.

4. Berman JR, Berman L, Goldstein I. Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options. Urology. 1999. 54:385–391.

5. Berman JR, Adhikari SP, Goldstein I. Anatomy and physiology of female sexual function and dysfunction. Eur Urol. 2000. 38:20–29.

6. Guay A. Premenopausal and postmenopausal women with low libido have decreased testosterone and dehydroepiandrosterone-sulfate(DHEA-S) levels. Proceedings of female sexual function forum 3rd annual meeting. 2000. Boston: Female sexual function forum;56.

7. Tuiten A, Van HJ, Koppeschaar H, Bernaards C, Thijssen J, Verbaten R. Time course of effects of testosterone administration on sexual arousal in women. Arch Gen Psychiatry. 2000. 57:149–153.

8. Ayton RA, Darling GM, Murkies AL, Farrell EA, Weisberg E, Selinus I, et al. A comparative study of safety and efficacy of continous low dose estradiol released from a vaginal ring compared with conjugated equine estrogen vaginal cream in the treatment of postmenopausal vaginal atrophy. Br J Obstet Gynaecol. 1996. 103:351–358.

9. Laan E, Everaerd W. Physiologic measure of vaginal vasocongestion. Int J Impot Res. 1998. 10:S107–S110.

10. Laan E, van Lunsen RHW, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric. 2001. 4:28–41.

11. Bachmann G, Bancroft J, Braunstein G, Bruger H, Davis S, Dennerstein L, et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril. 2002. 77(4):660–665.

12. Flynn MA, Weaver-Osterholtz D, Sharpe-Timms KL, Allen S, Krause G. Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab. 1999. 84:1527–1533.

13. Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, et al. Dehydroepiandrosterone(DHEA), DHEA sulfate, and aging: contribution of the DHEAge study to a sociobiomedical issue. Proc Natl Acad Sci. 2000. 97:4279–4284.

14. Talalkoub L, Munarriz R, De E, Garcia S, Kim NN, Goldstine I, et al. Dehydroepiandrosterone(DHEA) treatment for female androgen insufficiency and sexual dysfunction: baseline and post-treatment biochemical data. Proceedings of Female Sexual Function Forum 4th Annual Meeting. 2001. Boston: Female Sexual Function Forum;123.

15. Kaplan SA, Rodolfo RB, Kohn IJ, Ikeguchi EF, Laor E, Te AE, et al. Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. Urology. 1999. 53:481–486.

16. Kegel AH. Sexual function of the pubococcygeal muscle. West J Surg Obstet Gynecol. 1952. 60:521–524.

17. Graber B. Female orgasm: role of pubococcygeus muscle. J Clin Psychiatry. 1979. 40:348–351.

TOOLS

Similar articles